|
End-of-day quote
Shanghai S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 5.140 CNY | +1.58% |
|
+1.18% | -7.05% |
| 04/08 | North China Pharmaceutical's Eight Products Win Preliminary Bids Under Government Drug Procurement Program | MT |
| 25/05 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| Market Cap | 842.42Cr 125.25Cr 107.24Cr 100.06Cr 92Cr 172.52Cr 12TCr 175.91Cr 1.19TCr 462.71Cr 6.01TCr 470.28Cr 460.05Cr 20TCr | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.81TCr 269.08Cr 230.38Cr 214.95Cr 197.24Cr 370.62Cr 26TCr 377.92Cr 2.55TCr 994.05Cr 13TCr 1.01TCr 988.34Cr 43TCr | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.58% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | +1.58% | ||
| 1 week | +1.18% | ||
| Current month | +6.64% | ||
| 1 month | +5.76% | ||
| 3 months | +6.64% | ||
| 6 months | -6.55% | ||
| Current year | -7.05% |
| 1 week | 4.88 |  | 5.22 |
| 1 month | 4.65 | | 5.22 |
| Current year | 4.11 | | 6.07 |
| 1 year | 4.11 | | 6.63 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Li Xin Wang
CHM | Chairman | 54 | 10/04/2023 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.58% | +1.18% | -22.00% | -9.51% | 131.12Cr | |
| +1.24% | +6.50% | +77.07% | +128.50% | 1,10900Cr | |
| +1.74% | +4.10% | +51.47% | +61.95% | 64TCr | |
| +1.31% | +6.34% | +26.63% | +76.66% | 46TCr | |
| +0.23% | +4.73% | +41.68% | +46.24% | 37TCr | |
| +0.66% | +3.48% | +23.18% | +40.78% | 30TCr | |
| +0.87% | +6.28% | +1.10% | +14.11% | 26TCr | |
| +1.69% | +5.59% | +48.24% | +68.18% | 23TCr | |
| +1.02% | +1.73% | -15.81% | -52.46% | 20TCr | |
| +2.65% | +6.28% | +26.61% | +93.64% | 18TCr | |
| Average | +1.32% | +2.90% | +25.82% | +46.81% | 37.62TCr | |
| Weighted average by Cap. | +1.28% | +3.26% | +44.25% | +72.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 986.96Cr 146.74Cr 125.64Cr 117.22Cr 107.56Cr 202.12Cr 14TCr 206.09Cr 1.39TCr 542.09Cr 7.04TCr 550.97Cr 538.98Cr 23TCr | 924.17Cr 137.4Cr 117.64Cr 109.76Cr 100.72Cr 189.26Cr 13TCr 192.98Cr 1.3TCr 507.6Cr 6.59TCr 515.92Cr 504.69Cr 22TCr |
| Net income | 13Cr 1.89Cr 1.62Cr 1.51Cr 1.38Cr 2.6Cr 180.66Cr 2.65Cr 18Cr 6.98Cr 91Cr 7.09Cr 6.94Cr 299.75Cr | 18Cr 2.72Cr 2.33Cr 2.17Cr 2Cr 3.75Cr 260.42Cr 3.82Cr 26Cr 10Cr 130.51Cr 10Cr 10Cr 432.08Cr |
| Net Debt | 978.97Cr 145.55Cr 124.62Cr 116.27Cr 106.69Cr 200.48Cr 14TCr 204.42Cr 1.38TCr 537.7Cr 6.98TCr 546.51Cr 534.62Cr 23TCr | 967.38Cr 143.83Cr 123.14Cr 114.9Cr 105.43Cr 198.11Cr 14TCr 202.01Cr 1.36TCr 531.34Cr 6.9TCr 540.04Cr 528.29Cr 23TCr |
Employees
9,972
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | CN¥5.140 | +1.58% | 2,93,97,277 |
| 19/26/19 | CN¥5.060 | -1.94% | 3,04,06,512 |
| 18/26/18 | CN¥5.160 | +2.18% | 3,50,76,975 |
| 17/26/17 | CN¥5.050 | +0.20% | 2,41,90,500 |
| 14/26/14 | CN¥5.040 | -0.79% | 2,33,56,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
